Abstract
The perception of pain is the result of complicated physiological and psychological processes. Pain can be treated by interrupting peripheral inputs, or by modulation of pain signals in the central nervous system. One approach that has been particularly successful has involved use of drugs that increase activity in brain and spinal cord pathways that inhibit transmission of pain signals. Drugs that increase serotonin and norepinephrine (Serotonin Norepinephrine Reuptake Inhibitors - SNRIs) have been found to be effective. These drugs are known to have antidepressant activity, and are widely used to treat depression. Although there is overlap between pain and depression, the reason these drugs are effective for treatment of pain appears to result from a direct effect on pain pathways in the central nervous system. Mechanisms of action and clinical utility of SNRIs in treatment of chronic pain are reviewed.
Keywords: serotonin/norepinephrine specific reuptake inhibitors, Diabetic Peripheral Neuropathic Pain, Postherpetic Neuralgia, HIV, Fibromyalgia, Pelvic Pain
Current Drug Therapy
Title: Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine
Volume: 2 Issue: 2
Author(s): Joachim F. Wernicke, Smriti Iyengar and M. Dolores Ferrer-Garcia
Affiliation:
Keywords: serotonin/norepinephrine specific reuptake inhibitors, Diabetic Peripheral Neuropathic Pain, Postherpetic Neuralgia, HIV, Fibromyalgia, Pelvic Pain
Abstract: The perception of pain is the result of complicated physiological and psychological processes. Pain can be treated by interrupting peripheral inputs, or by modulation of pain signals in the central nervous system. One approach that has been particularly successful has involved use of drugs that increase activity in brain and spinal cord pathways that inhibit transmission of pain signals. Drugs that increase serotonin and norepinephrine (Serotonin Norepinephrine Reuptake Inhibitors - SNRIs) have been found to be effective. These drugs are known to have antidepressant activity, and are widely used to treat depression. Although there is overlap between pain and depression, the reason these drugs are effective for treatment of pain appears to result from a direct effect on pain pathways in the central nervous system. Mechanisms of action and clinical utility of SNRIs in treatment of chronic pain are reviewed.
Export Options
About this article
Cite this article as:
Wernicke F. Joachim, Iyengar Smriti and Dolores Ferrer-Garcia M., Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine, Current Drug Therapy 2007; 2 (2) . https://dx.doi.org/10.2174/157488507780619086
DOI https://dx.doi.org/10.2174/157488507780619086 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter
Current Pharmaceutical Design Essential Hypertension: Translating Pathophysiology into Pharmacogenomics
Current Pharmacogenomics Microwave Assisted Medicinal Chemistry
Mini-Reviews in Medicinal Chemistry New Insight into the Therapeutic Role of 5-HT1A Receptors in Central Nervous System Disorders
Central Nervous System Agents in Medicinal Chemistry Hepatic Encephalopathy: Cause and Possible Management with Botanicals
Recent Patents on Inflammation & Allergy Drug Discovery Current Drug Targets and Future Therapy of Pulmonary Arterial Hypertension
Current Medicinal Chemistry The Effect of Sex and Gender on Diabetic Complications
Current Diabetes Reviews Serelaxin: New Investigational Treatment in Acute Heart Failure
Cardiovascular & Hematological Agents in Medicinal Chemistry Painful Peripheral Neuropathies
Current Neuropharmacology Advances in L-Type Calcium Channel Structures, Functions and Molecular Modeling
Current Medicinal Chemistry Therapeutic Interventions in the Glyc(oxid)ation Pathway
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Heart Failure in South America
Current Cardiology Reviews Synthesis and Study the Antimicrobial Activity of Novel 2-(1H-indol-3-yl)- N-(3, 4-diphenylthiazol-2(3H)-ylidene) Ethanamine Derivatives
Medicinal Chemistry Melphalan in Regional Chemotherapy for Locally Recurrent Metastatic Melanoma
Current Topics in Medicinal Chemistry Identification of L-Amino Acid Oxidase (Mb-LAAO) with Antibacterial Activity in the Venom of Montivipera bornmuelleri, a Viper from Lebanon
Infectious Disorders - Drug Targets Atrial Fibrillation with a Focus on Oral Antiarrhythmic Therapy
Current Drug Therapy Immunological Impact of Whey Protein on Peripheral Blood Mononuclear Cells of Patients with Chronic Liver Disease
Current Nutrition & Food Science Interaction Between Bone and Muscle in Older Persons with Mobility Limitations
Current Pharmaceutical Design Endothelin Receptor Antagonists: Another Potential Alternative for Cardiovascular Diseases
Current Drug Targets - Cardiovascular & Hematological Disorders Fetal Undernutrition and the Programming of Blood Pressure
Current Nutrition & Food Science